How much cash does bioAffinity Technologies have?

According to bioAffinity Technologies's latest annual financial reports, the company has a total of $2.82M in cash and cash equivalents. This amount includes all liquid assets that can be readily converted into cash.

Additionally, bioAffinity Technologies holds $- in short-term investments, which are highly liquid assets that can be easily converted into cash within a short period.

In total, the company has $2.82M when combining cash and cash equivalents with short-term investments.

On a per-share basis, bioAffinity Technologies has $0.32 in cash. This metric helps investors understand how much cash the company holds per outstanding share.

The company's free cash flow, which is the cash generated from operations after deducting capital expenditures, stands at $-6.06M. This is an important indicator of financial health, showing the cash available for distribution to shareholders or reinvestment into the company.

Lastly, the company's cash position has experienced a growth rate of -75.28%, reflecting the increase in cash and cash equivalents over the specified period.

bioAffinity Technologies Historical Cash on Hand

Cash on Hand History

The table below shows the amount of cash on hand for each year, with the latest data available for the last fiscal year 2023.

Year	Cash on Hand	Change
2023	$2.82M	-75.28%
2022	$11.41M	738.85%
2021	$1.36M	1537.19%
2020	$83.11K	-85.63%
2019	$578.48K	N/A